Evidence map›Paper›PMID 41008889›Full record

ArticleCancers2025

Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing.

Miguel Muniz, L Jill Tsai, Jacob J Orme, Leslie A Bucheit, Spyridon P Basourakos, Nancy Wei, Regina M Koch, Zachary Scharf, Sounak Gupta, Adam M Kase and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Miguel MunizDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0004-7268-5077
L Jill TsaiGuardant Health, Palo Alto, CA 94304, USA.
Jacob J OrmeDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-0319-0239
Leslie A BucheitGuardant Health, Palo Alto, CA 94304, USA.
Spyridon P BasourakosDepartment of Urology, Mayo Clinic, Rochester, MN 55905, USA.
Nancy WeiDepartment of Urology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0005-7432-1282
Regina M KochDepartment of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Zachary ScharfDepartment of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0008-6686-4721
Sounak GuptaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-5163-6955
Adam M KaseDepartment of Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.ORCID 0000-0002-1862-8467
Rodrigo Rodrigues PessoaDepartment of Urology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Irbaz B RiazDivision of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Eugene D KwonDepartment of Urology, Mayo Clinic, Rochester, MN 55905, USA.
Jack R AndrewsDepartment of Urology, Mayo Clinic, Phoenix, AZ 85054, USA.
Daniel S ChildsDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-7643-2836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circulating tumor DNAgenomic testingliquid biopsyprostate cancer

Identifiers

PMID41008889
PMCPMC12468080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.